Cereno Scientific publishes interim report for Q3 2020 (1 January – 30 September 2020)
The Board and Chief Executive Officer of Cereno Scientific AB here presents the interim report for the third quarter 2020.Summary of the interim report Cereno Scientific Group Year to date (1 January – 30 September 2020) · Net Sales were 0 SEK · Loss after financial items was SEK 10 907 101 · Loss per share was SEK 0.27 before dilution and SEK 0.25 after dilution · The equity/assets ratio was 86.3 % Third quarter (1 July 2020 – 30 September 2020) · Net Sales were 0 SEK · Loss after financial items was SEK 3 132 513 · Loss per share was SEK 0.08 before